MMJ PhytoTech Limited announced that it has further strengthened its senior management personnel with the appointment of Richard Jarvis as Chief Financial Officer. Mr. Jarvis will be responsible for all finance and accounting aspects of the Group, including the management of financial risk and leading financial strategy and planning. He will provide valuable financial support and guidance through the complexity of a multi-jurisdictional business model, as the company continues to advance its vertically integrated ‘Farm to Pharma’ strategy. Mr. Jarvis is a Chartered Certified Accountant with twenty years experience in professional accountancy and finance leadership roles. The first ten years of his career he spent working in a business advisory capacity both in the UK and Australia, providing professional accounting services to a diverse client base. For the last ten years he has held senior managerial roles, including acting as Chief Financial Officer for a number of publicly-listed companies with international operations, listed on the Australian Stock Exchange and/or the AIM market of the London Stock Exchange.